Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
the study's lead author and a professor of radiology in the University of Pennsylvania Perelman School of Medicine, said in a statement that the findings were "observational" and do not "definitively confirm an association between GLP-1 medications and reduced breast cancer incidence," however the study "does add to the growing body of evidence suggesting that it's worth investigating these weight-loss drugs as potential cancer prevention tools." Narula reiterated that the new study is "hypothesis-generating" not "practice-changing," though the study does add to a growing body of similar research
*Lindora GLP-1s are compounded products and have not been approved by the FDA
Why is peptide so expensive
When sourcing reference material for receptor pharmacology or analytical verification workflows, confirm CAS 2381089-83-2, lot identifiers, and COA-backed purity data rather than informal naming alone
